9 November 2018 - Today, the U.S. FDA is providing a summary of the generic drug approval actions for the month of October 2018 as part of its efforts to improve patient access to high-quality, lower cost, safe and effective medicines.
In October, the FDA approved 110 generic drugs and tentatively approved 18 generic drugs, for a total of 128 approval actions.
This included 23 first generics for brands that lacked competition and 17 complex generics.